FDA Approves New ADHD Medication

Дата публикации: 14-08-2026 00:00:00

The US Food and Drug Administration (FDA) approved a new medication for the treatment of attention-deficit/hyperactivity disorder (ADHD).

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Gene therapy for children with sickle cell disease approved by FDA	5	7	08-07-2026
2	New PILL for psoriasis approved... giving hope to millions suffering from debilitating skin condition	0	5.26	18-03-2026
3	Autism breakthrough as scientists find 44-cent pill that 'reverses' symptoms	0	9.48	09-04-2026
4	Alkermes Granted Orphan Drug Designations for Alixorexton in US, Europe	0	5	16-06-2026
5	ADHD Defects and Differences	0	14.75	24-07-2026
6	FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients	5	7	18-07-2026
7	FDA одобрило новый противогриппозный препарат Xofluza	0	0	25-10-2018
8	FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia	0	10.55	19-08-2026
9	Granules secures FTF status for CNS depressant generic	2	3	06-07-2026
10	Popular drug used to treat epilepsy, bipolar disorder recalled nationwide: Here's why	0	4.08	24-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.53. Источник: jamanetwork.com.